- About Us
- Advertise
- Contact Us
- CureToday.com
- CancerNetwork.com
- OncLive.com
- Do Not Sell My Information
- Privacy
- Terms & Conditions
© 2021 MJH Life Sciences™ , Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways. All rights reserved.
Latest Oncology News
Maintenance Therapy for Newly Diagnosed Follicular Lymphoma
November 30, 2021
Factors that affect the use of maintenance therapy, including anti-CD20 maintenance therapy, for newly diagnosed follicular lymphoma, and recommendations for assessing response to therapy.
Newly Diagnosed Follicular Lymphoma: First-Line Anti-CD20 Therapy
November 30, 2021
The rationale for treating newly diagnosed follicular lymphoma with the anti-CD20 monoclonal antibody, obinutuzumab, in the first-line setting.
Newly Diagnosed Follicular Lymphoma: Frontline Treatment Decisions
November 30, 2021
Goals of therapy and variables that affect how patients with newly diagnosed follicular lymphoma are managed with chemoimmunotherapy in the frontline setting, including during COVID-19.
Criteria Used in the Initial Diagnosis of Follicular Lymphoma
November 30, 2021
Recommendations for assessing and risk stratifying patients with newly diagnosed follicular lymphoma, with special considerations regarding the current role of molecular testing.
Case Impressions: A Woman With Newly Diagnosed Follicular Lymphoma
November 30, 2021
Similarities between the management of a hypothetical case of newly diagnosed follicular lymphoma compared with what is done in real-world practice.
Frontline car-BIRD Regimen Shows Potential for Patients With Multiple Myeloma
November 30, 2021
In an interview with Targeted Oncology, Ruben Niesvizky, MD, discussed current efficacy outcomes in multiple myeloma and how the introduction of the car-BIRD regimen may improve upon them.
Study Explores Combination of 2 Cancer Vaccine for HPV16+ Cancers
November 29, 2021
Marshall Posner, MD, discusses a study exploring the use of HB-201 and HB-202 vaccines in patients with HPV16-positive cancers.
Part 1: Guidelines and Recommendations for Treating nmCRPC
November 29, 2021
During a live virtual event, Eleni Efstathiou, MD, PhD, discussed the recommended approach to front-line treatment of castration-resistant prostate cancer.
The Potential of Rebastinib in Platinum-Resistant Ovarian Cancer Treatment
November 29, 2021
Erika Hamilton, MD, discusses the mechanism of action of rebastinib, which is currently being explored in combination with weekly paclitaxel 1b/2 study of patients with platinum-resistant ovarian cancer.
ICU Admission, Oxygen Use Predict Outcomes in Patients With Cancer and COVID-19
November 29, 2021
Markus Joerger, MD, discussed the outcomes and prognostic factors of patients with cancer won contract COVID-19 in an interview with Targeted Oncology.
Novel Cabazitaxel Formulation Shows Promise for Metastatic Prostate Cancer
November 29, 2021
Efficacy signals have been shown in 100% of patients with metastatic prostate cancer treated with a new formulation of cabazitaxel.
FDA 'Fast Tracks' Arfolitixorin for Metastatic Colorectal Cancer
November 29, 2021
After 40 years, a novel agent may be on the fast track to becoming the first drug to improve the standard of care for patients with metastatic colorectal cancer.